Societal CDMO Inc
NASDAQ:SCTL
Societal CDMO Inc
Accumulated Depreciation
Societal CDMO Inc
Accumulated Depreciation Peer Comparison
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Societal CDMO Inc
NASDAQ:SCTL
|
Accumulated Depreciation
-$52.5m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Accumulated Depreciation
-$28B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Accumulated Depreciation
-$4.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-1%
|
|
Pfizer Inc
NYSE:PFE
|
Accumulated Depreciation
-$16.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Accumulated Depreciation
-$18.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Accumulated Depreciation
-$11.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
See Also
What is Societal CDMO Inc's Accumulated Depreciation?
Accumulated Depreciation
-52.5m
USD
Based on the financial report for Dec 31, 2023, Societal CDMO Inc's Accumulated Depreciation amounts to -52.5m USD.
What is Societal CDMO Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-23%
Over the last year, the Accumulated Depreciation growth was -18%. The average annual Accumulated Depreciation growth rates for Societal CDMO Inc have been -19% over the past three years , -23% over the past five years .